IgE as a predictor to omalizumab response in patients with chronic spontaneous urticaria

IgE as a predictor to omalizumab response in patients with chronic spontaneous urticaria

This multicenter study aimed to explore whether baseline total immunoglobulin E (IgE) levels could predict omalizumab response in chronic spontaneous urticaria (CSU) patients. Refractory CSU patients, treated with omalizumab after failing second-generation H1-antihistamines, were analyzed retrospect...

Full description

Saved in:
Bibliographic Details
Main Authors: Luis Felipe Ensina, Larissa Brandão, Luisa Karla Arruda, Faradiba Sarquis Serpa, Régis Albuquerque Campos, Solange Rodrigues Oliveira Valle, Paulo Ricardo Criado, Sarbjit Singh Saini, Roberta Fachini Jardim Criado
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Allergy
Subjects:
urticaria
immunoglobulin E
omalizumab
biomarkers
treatment
Online Access:https://www.frontiersin.org/articles/10.3389/falgy.2024.1451296/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/falgy.2024.1451296/full

Similar Items